Herriot Tabuteau Axsome Therapeutics, Inc. (AXSM) insider trading activity

AXSM Quotes by TradingView

Herriot Tabuteau is Chief Executive Officer of Axsome Therapeutics, Inc.. Currently has a direct ownership of 7,229 shares of AXSM, which is worth approximately $1.01 Million. The most recent transaction as insider was on Sep 16, 2025, when has been sold 19,719 shares (Common Stock) at a price of $8.02 per share, resulting in proceeds of $158,146. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.23K
0% 3M change
n/a 12M change
Total Value Held $1.01 Million

HERRIOT TABUTEAU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2025
BUY
Exercise of conversion of derivative security
$158,146 $8.02 p/Share
19,719 Added 42.25%
26,948 Common Stock
Sep 15 2025
SELL
Open market or private sale
$1,790,361 $117.37 p/Share
15,254 Reduced 67.85%
7,229 Common Stock
Sep 15 2025
BUY
Exercise of conversion of derivative security
$122,337 $8.02 p/Share
15,254 Added 40.42%
22,483 Common Stock
Sep 12 2025
SELL
Open market or private sale
$3,319,816 $118.96 p/Share
27,907 Reduced 79.43%
7,229 Common Stock
Sep 12 2025
BUY
Exercise of conversion of derivative security
$223,814 $8.02 p/Share
27,907 Added 44.27%
35,136 Common Stock
HT

Herriot Tabuteau

Chief Executive Officer
New York, NY

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AXSM